Johnson & Johnson Reports 2016 Fourth-Quarter Results:
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Johnson & Johnson (JNJ) PT Lowered to $141 at UBS Following 4Q Report
January 25, 2017 8:12 AM ESTUBS lowered its price target on Johnson & Johnson (NYSE: JNJ) to $141.00 (from $142.00) while maintaining a Buy rating following the company's 4Q earnings report.
Analyst Matt Miksic commented, "After making appropriate adjustments for year-over-year shipping day differences, JNJ's Q4 sales were up... More
Johnson & Johnson (JNJ) Tops Q4 EPS by 2c; Guides Modestly Below the Street
January 24, 2017 6:42 AM ESTJohnson & Johnson (NYSE: JNJ) reported Q4 EPS of $1.58, $0.02 better than the analyst estimate of $1.56. Revenue for the quarter came in at $18.1 billion versus the consensus estimate of $18.28 billion.
GUIDANCE:
Johnson & Johnson sees FY2017 EPS of $6.93-$7.08, versus the consensus of $7.11.... More
